Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
Year: 2023
Type: article
Study design: Observational Study
Source: European Journal of Cancer
Authors: Ammoren E. Dohm, Justyn Y. Nakashima, Hruday Kalagotla, Shirley X. Jiang, Joseph D. Tang, Menal Bhandari, Youngchul Kim, Jasmine A. Graham, Nikhil I. Khushalani, Peter A. Forsyth, Arnold B. Etame, James K. Liu, Nam D. Tran, Michael A. Vogelbaum, Evan J. Wuthrick, Hsiang-Hsuan Michael Yu, Daniel E. Oliver, Kamran A. Ahmed
Institution: Moffitt Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4385617849